tocophersolan has been researched along with Ovarian Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Qi, Z; Shi, J; Song, Y | 1 |
| Gong, Y; Li, Y; Li, Z; Wu, T; Xiong, X | 1 |
| Hussain, MD; Saxena, V | 1 |
| Bao, Y; Cheng, B; Guo, Y; Li, D; Tan, S; Zhang, Z; Zhuang, X | 1 |
| Bao, Y; Chu, Q; Tan, S; Wu, T; Wu, Y; Zhang, Z; Zhuang, X | 1 |
| Bernabeu, E; Cagel, M; Chiappetta, DA; Gergic, EP; Gonzalez, L; Moretton, MA | 1 |
| Chandran, T; Katragadda, U; Rayaprolu, BM; Tan, C; Teng, Q | 1 |
7 other study(ies) available for tocophersolan and Ovarian Neoplasms
| Article | Year |
|---|---|
A novel micellar carrier to reverse multidrug resistance of tumours: TPGS derivatives with end-grafted cholesterol.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cholesterol; Docetaxel; Drug Resistance, Multiple; Female; Humans; Mice; Mice, Nude; Micelles; Ovarian Neoplasms; Polyethylene Glycols; Vitamin E | 2023 |
Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery.
Topics: Apoptosis; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Folic Acid; Humans; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Poloxamer; Polyethylene Glycols; Vitamin E | 2021 |
Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Curcumin; Delayed-Action Preparations; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Micelles; Nanocapsules; Ovarian Neoplasms; Poloxamer; Polyethylene Glycols; Treatment Outcome; Vitamin E | 2013 |
D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Half-Life; Humans; Mice; Micelles; Ovarian Neoplasms; Oxidation-Reduction; Paclitaxel; Polyethylene Glycols; Prodrugs; Rats; Rats, Sprague-Dawley; Vitamin E | 2014 |
D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Lung Neoplasms; MCF-7 Cells; Mice; Micelles; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Sarcoma; Succinates; Vitamin E | 2015 |
Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Liberation; Female; Humans; Immunoblotting; MCF-7 Cells; Micelles; Microscopy, Electron, Transmission; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; Polyvinyls; Solubility; Vitamin E | 2016 |
Multi-drug delivery to tumor cells via micellar nanocarriers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Delivery Systems; Female; Half-Life; Humans; Lactams, Macrocyclic; Micelles; Nanoparticles; Ovarian Neoplasms; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols; Vitamin E | 2011 |